These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37310469)

  • 1. Identification of a novel MSI-related ceRNA network for predicting the prognosis and immunotherapy response of gastric cancer.
    Zhang L; Cao L; Liu J; Duan L; Zhou W; Li T; Guan L; Wu X; Zhang H
    Aging (Albany NY); 2023 Jun; 15(11):5164-5189. PubMed ID: 37310469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a potential long noncoding RNA prognostic model involved competitive endogenous RNA for patients with gastric cancer.
    Xi T; Zhou Y; Ma S; Lu W; Sun Y; Sun C; Zhou Y
    Medicine (Baltimore); 2024 Jun; 103(24):e38458. PubMed ID: 38875399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Analysis of lncRNA-Associated ceRNA Network Identifies Two lncRNA Signatures as a Prognostic Biomarker in Gastric Cancer.
    Zhang S; Li S; Guo JL; Li N; Zhang CN; Liu J
    Dis Markers; 2021; 2021():8886897. PubMed ID: 34603561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
    Zhang X; Zhang W; Jiang Y; Liu K; Ran L; Song F
    J Cell Biochem; 2019 Oct; 120(10):17898-17911. PubMed ID: 31135068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of lncRNA-associated competing endogenous RNA networks for occurrence and prognosis of gastric carcinoma.
    Ye L; Jin W
    J Clin Lab Anal; 2021 Dec; 35(12):e24028. PubMed ID: 34704289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
    Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
    Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gastric cancer LncRNAs model for MSI and survival prediction based on support vector machine.
    Chen T; Zhang C; Liu Y; Zhao Y; Lin D; Hu Y; Yu J; Li G
    BMC Genomics; 2019 Nov; 20(1):846. PubMed ID: 31722674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration.
    Zhang K; Zhang L; Mi Y; Tang Y; Ren F; Liu B; Zhang Y; Zheng P
    Cancer Sci; 2020 Nov; 111(11):4041-4050. PubMed ID: 32860283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer.
    Qi M; Yu B; Yu H; Li F
    Cancer Med; 2020 Mar; 9(5):1798-1817. PubMed ID: 31923354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
    Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z
    Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the ferroptosis-related ceRNA network related to prognosis and tumor immunity for gastric cancer.
    Xiang Z; Zhou X; Mranda GM; Xue Y; Wang Y; Wei T; Liu J; Ding Y
    Aging (Albany NY); 2022 Jul; 14(14):5768-5782. PubMed ID: 35835721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer.
    Zhao Z; Mak TK; Shi Y; Huang H; Huo M; Zhang C
    Front Immunol; 2023; 14():1117255. PubMed ID: 37457685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Immune-related ceRNA Network in Prognosis of Cervical Cancer.
    Dhandapani H; Bose M; Kesavan S
    Asian Pac J Cancer Prev; 2022 Oct; 23(10):3347-3354. PubMed ID: 36308358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Novel Biomarkers for Predicting Prognosis and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma Based on ceRNA Network and Immune Infiltration Analysis.
    Guo Y; Pan WK; Wang ZW; Su WH; Xu K; Jia H; Chen J
    Biomed Res Int; 2021; 2021():4532438. PubMed ID: 34917682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
    Tan Y; Lu L; Liang X; Chen Y
    World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients.
    Cao W; Zhou W; Li M; Zhang Z; Zhang X; Yang K; Yang S; Cao G; Chen B; Xiong M
    Front Immunol; 2022; 13():951135. PubMed ID: 36483555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
    Yu H; Cheng Y; Li W; Li Z; Wu P; Qiu S; Zeng B; Huang B
    Life Sci; 2020 Nov; 260():118409. PubMed ID: 32926921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of an immune infiltrate-related competitive endogenous RNA network reveals potential prognostic biomarkers for non-small cell lung cancer.
    Yang CZ; Hu LH; Huang ZY; Deng L; Guo W; Liu S; Xiao X; Yang HX; Lin JT; Sun LL; Lin LZ
    PLoS One; 2021; 16(12):e0260720. PubMed ID: 34855841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.